{"id":71767,"date":"2026-04-30T08:44:17","date_gmt":"2026-04-30T08:44:17","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/71767\/"},"modified":"2026-04-30T08:44:17","modified_gmt":"2026-04-30T08:44:17","slug":"jim-cramer-believes-novo-nordisk-is-going-to-lose-a-lot-of-share-on-the-pill-to-eli-lilly","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/71767\/","title":{"rendered":"Jim Cramer Believes \u201cNovo Nordisk Is Going to Lose a Lot of Share on the Pill to Eli Lilly\u201d"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">Novo Nordisk A\/S (NYSE:<a href=\"https:\/\/finance.yahoo.com\/quote\/NVO\" data-ylk=\"slk:NVO;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;NVO&quot;}\" class=\"link \" rel=\"nofollow noopener\" target=\"_blank\">NVO<\/a>) was among the <a href=\"https:\/\/www.insidermonkey.com\/blog\/jim-cramers-23-stocks-arm-qxo-and-the-markets-biggest-threat-1749227\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:stocks Jim Cramer covered on Mad Money as he discussed the wave of IPOs being the market\u2019s possible biggest threat;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;stocks Jim Cramer covered on Mad Money as he discussed the wave of IPOs being the market\u2019s possible biggest threat&quot;}\" class=\"link \">stocks Jim Cramer covered on Mad Money as he discussed the wave of IPOs being the market\u2019s possible biggest threat<\/a>. A caller asked if they should hold the stock or not, and in response, Cramer said:<\/p>\n<p class=\"yf-1kwbn3\">Oh, Novo Nordisk, no, look, Eli Lilly\u2019s struggling right here. I think, and Novo Nordisk is going to lose a lot of share on the pill to Eli Lilly. So I say no, we don\u2019t want to be there.<\/p>\n<p>     <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/02\/86b6f1eab4d4c0ffbf065f3a834e0a1b.jpeg\" alt=\"\" loading=\"eager\" height=\"640\" width=\"960\" class=\"yf-lglytj  loaded\"\/>     <\/p>\n<p class=\"yf-1fy9kyt\">Photo by <a href=\"https:\/\/unsplash.com\/@adamaszczos?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Adam Nowakowski;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Adam Nowakowski&quot;}\" class=\"link \">Adam Nowakowski<\/a> on <a href=\"https:\/\/unsplash.com\/?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Unsplash;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Unsplash&quot;}\" class=\"link \">Unsplash<\/a><\/p>\n<p class=\"yf-1fy9kyt\">Novo Nordisk A\/S (NYSE:NVO) manufactures pharmaceuticals for chronic conditions, including diabetes, obesity, and rare blood or endocrine disorders. The company also produces some medical devices. On January 29, answering a caller\u2019s question about the stock, Cramer said:<\/p>\n<p class=\"yf-1kwbn3\">I kind of liked it when I spoke to them. I gotta tell you, I kind of warmed up\u2026 I was in San Francisco, and I said, you know what? I get that stock a little down more\u2026 But I love Eli Lilly and David Ricks, and what can I say? You know, as long as Eli Lilly and David Ricks are putting up those numbers and they get that pill form soon, I think that Novo is a hold, not a buy.<\/p>\n<p class=\"yf-1fy9kyt\">While we acknowledge the potential of NVO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you&#8217;re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the<a href=\"https:\/\/www.insidermonkey.com\/blog\/three-megatrends-one-overlooked-stock-massive-upside-1548959\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:best short-term AI stock;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;best short-term AI stock&quot;}\" class=\"link \"> best short-term AI stock<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">READ NEXT: <a href=\"https:\/\/www.insidermonkey.com\/blog\/33-stocks-that-should-double-in-3-years-1709437\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:33 Stocks That Should Double in 3 Years;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;33 Stocks That Should Double in 3 Years&quot;}\" class=\"link \">33 Stocks That Should Double in 3 Years<\/a> and <a href=\"https:\/\/www.insidermonkey.com\/blog\/15-stocks-that-will-make-you-rich-in-10-years-1711641\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:15 Stocks That Will Make You Rich in 10 Years;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;15 Stocks That Will Make You Rich in 10 Years&quot;}\" class=\"link \">15 Stocks That Will Make You Rich in 10 Years<\/a>\u00a0<\/p>\n<p class=\"yf-1fy9kyt\">Disclosure: None. <a href=\"https:\/\/news.google.com\/publications\/CAAqLQgKIidDQklTRndnTWFoTUtFV2x1YzJsa1pYSnRiMjVyWlhrdVkyOXRLQUFQAQ?hl=en-US&amp;gl=US&amp;ceid=US%3Aen\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Follow Insider Monkey on Google News;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Follow Insider Monkey on Google News&quot;}\" class=\"link \">Follow Insider Monkey on Google News<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Novo Nordisk A\/S (NYSE:NVO) was among the stocks Jim Cramer covered on Mad Money as he discussed the&hellip;\n","protected":false},"author":2,"featured_media":17570,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[12581,3265,276,16711,2961,272],"class_list":{"0":"post-71767","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-adam-nowakowski","9":"tag-david-ricks","10":"tag-eli-lilly","11":"tag-endocrine-disorders","12":"tag-jim-cramer","13":"tag-novo-nordisk"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116492780653338328","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/71767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=71767"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/71767\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/17570"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=71767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=71767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=71767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}